Skeletal muscle mitochondrial dysfunction and muscle and whole body functional deficits in cancer patients with weight loss
- 1 February 2022
- journal article
- research article
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 132 (2) , 388-401
Abstract
Reductions in skeletal muscle mass and function are often reported in patients with cancer-associated weight loss and are associated with reduced quality of life, impaired treatment tolerance, and increased mortality. Although cellular changes, including altered mitochondrial function, have been reported in animals, such changes have been incompletely characterized in humans with cancer. Whole body and skeletal muscle physical function, skeletal muscle mitochondrial function, and whole body protein turnover were assessed in eight patients with cancer-associated weight loss (10.1 ± 4.2% body weight over 6–12 mo) and 19 age-, sex-, and body mass index (BMI)-matched healthy controls to characterize skeletal muscle changes at the whole body, muscle, and cellular level. Potential pathways involved in cancer-induced alterations in metabolism and mitochondrial function were explored by interrogating skeletal muscle and plasma metabolomes. Despite similar lean mass compared with control participants, patients with cancer exhibited reduced habitual physical activity (57% fewer daily steps), cardiorespiratory fitness [22% lower V̇o2peak (mL/kg/min)] and leg strength (35% lower isokinetic knee extensor strength), and greater leg neuromuscular fatigue (36% greater decline in knee extensor torque). Concomitant with these functional declines, patients with cancer had lower mitochondrial oxidative capacity [25% lower State 3 O2 flux (pmol/s/mg tissue)] and ATP production [23% lower State 3 ATP production (pmol/s/mg tissue)] and alterations in phospholipid metabolite profiles indicative of mitochondrial abnormalities. Whole body protein turnover was unchanged. These findings demonstrate mitochondrial abnormalities concomitant with whole body and skeletal muscle functional derangements associated with human cancer, supporting future work studying the role of mitochondria in the muscle deficits associated with cancer. NEW & NOTEWORTHY To our knowledge, this is the first study to suggest that skeletal muscle mitochondrial deficits are associated with cancer-associated weight loss in humans. Mitochondrial deficits were concurrent with reductions in whole body and skeletal muscle functional capacity. Whether mitochondrial deficits are causal or secondary to cancer-associated weight loss and functional deficits remains to be determined, but this study supports further exploration of mitochondria as a driver of cancer-associated losses in muscle mass and function.Keywords
Funding Information
- Fred C. and Katherine B. Andersen Foundation (Andersen Foundation)
- HHS | NIH | National Cancer Institute (R01CA195473)
- HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32AR56950)
This publication has 75 references indexed in Scilit:
- IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the Apc Min/+ mouseSkeletal Muscle, 2012
- The role of insulin resistance in the development of muscle wasting during cancer cachexiaJournal of Cachexia, Sarcopenia and Muscle, 2011
- Measurement of human skeletal muscle oxidative capacity by 31P‐MR spectroscopy: A cross‐validation with in vitro measurementsJournal of Magnetic Resonance Imaging, 2011
- Accurate Determination of the Oxidative Phosphorylation Affinity for ADP in Isolated MitochondriaPLOS ONE, 2011
- Mitochondrial metabolic function assessed in vivo and in vitroCurrent Opinion in Clinical Nutrition and Metabolic Care, 2010
- Error associated with antagonist muscle activity in isometric knee strength testingEuropean Journal of Applied Physiology, 2010
- Chapter 20: Functional Assessment of Isolated Mitochondria In Vitro2009
- Endurance Exercise as a Countermeasure for AgingDiabetes, 2008
- Plasma lyso-phosphatidylcholine concentration is decreased in cancer patients with weight loss and activated inflammatory statusLipids in Health and Disease, 2007
- The Loss of Skeletal Muscle Strength, Mass, and Quality in Older Adults: The Health, Aging and Body Composition StudyThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2006